• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重复剂量的(-)司来吉兰对单胺能传递动力学的影响。与氯吉兰的比较。

The effect of repeated doses of (-) deprenyl on the dynamics of monoaminergic transmission. Comparison with clorgyline.

作者信息

Zsilla G, Földi P, Held G, Székely A M, Knoll J

出版信息

Pol J Pharmacol Pharm. 1986 Jan-Feb;38(1):57-67.

PMID:3020531
Abstract

The action of clorgyline and (-)deprenyl on the dynamics of dopaminergic and serotonergic transmission in the rat brain was compared. It was found, that daily administration of 0.25 mg/kg sc clorgyline, a specific MAO A inhibitor, reduced the turnover rate of both dopamine and serotonin after two weeks of injections. The treatment for two or four weeks with 0.25 mg/kg sc (-)deprenyl, a specific MAO B inhibitor, enhanced the turnover rate of dopamine and the fractional rate constant of dopamine efflux, reflecting an increased utilization rate of this amine in the striatum. Beside the augmentation of the dopamine turnover rate, the dopaminergic tone was also elevated by the reduction of the dopamine uptake in the striatum. Two week injections with the same dose of (-)deprenyl did not change the dynamics of serotonergic transmission.

摘要

比较了氯吉兰和(-)司来吉兰对大鼠脑内多巴胺能和5-羟色胺能传递动力学的作用。结果发现,每天皮下注射0.25mg/kg的氯吉兰(一种特异性单胺氧化酶A抑制剂),在注射两周后可降低多巴胺和5-羟色胺的更新率。用0.25mg/kg皮下注射(-)司来吉兰(一种特异性单胺氧化酶B抑制剂)进行两周或四周治疗,可提高多巴胺的更新率和多巴胺流出的分数速率常数,这反映出纹状体内该胺的利用率增加。除了多巴胺更新率增加外,纹状体内多巴胺摄取减少也使多巴胺能张力升高。用相同剂量的(-)司来吉兰注射两周并未改变5-羟色胺能传递的动力学。

相似文献

1
The effect of repeated doses of (-) deprenyl on the dynamics of monoaminergic transmission. Comparison with clorgyline.重复剂量的(-)司来吉兰对单胺能传递动力学的影响。与氯吉兰的比较。
Pol J Pharmacol Pharm. 1986 Jan-Feb;38(1):57-67.
2
[Effect of solubilization by methylethylketone of rat liver mitochondrial monoamine oxidase on inhibition by clorgyline and deprenyl of the enzyme activity].[甲基乙基酮对大鼠肝脏线粒体单胺氧化酶的增溶作用对氯吉兰和司来吉兰抑制该酶活性的影响]
Biokhimiia. 1981 Nov;46(11):2043-55.
3
Inhibition of monoamine oxidase-B by (-)-deprenyl potentiates neuronal responses to dopamine agonists but does not inhibit dopamine catabolism in the rat striatum.(-)-司来吉兰对单胺氧化酶-B的抑制作用增强了大鼠纹状体中神经元对多巴胺激动剂的反应,但并不抑制多巴胺的分解代谢。
J Pharmacol Exp Ther. 1991 Sep;258(3):1019-26.
4
R-(-)-deprenyl (Selegiline, Movergan) facilitates the activity of the nigrostriatal dopaminergic neuron.R-(-)-司来吉兰(Selegiline,Movergan)可促进黑质纹状体多巴胺能神经元的活性。
J Neural Transm Suppl. 1987;25:45-66.
5
[Effect of protein denaturing reactions on retardation of the activity of rat liver mitochondrial monoamine oxidase by clorgyline and deprenyl].[蛋白质变性反应对氯吉兰和司来吉兰抑制大鼠肝线粒体单胺氧化酶活性的影响]
Biokhimiia. 1983 Sep;48(9):1513-21.
6
Release of endogenous dopamine from rat isolated striatum: effect of clorgyline and (-)-deprenyl.大鼠离体纹状体中内源性多巴胺的释放:氯吉兰和(-)-司来吉兰的作用。
Br J Pharmacol. 1984 Nov;83(3):741-9. doi: 10.1111/j.1476-5381.1984.tb16228.x.
7
[Possible mechanism of selective inhibition of rat liver mitochondrial monoamine oxidase by chlorgiline and deprenyl].[氯吉兰和司来吉兰对大鼠肝线粒体单胺氧化酶的选择性抑制作用机制]
Biokhimiia. 1979 Feb;44(2):195-207.
8
Alteration of dopamine synthesis in rat striatum subsequent to selective type A monoamine oxidase inhibition.选择性A型单胺氧化酶抑制后大鼠纹状体中多巴胺合成的改变。
J Neurochem. 1981 Aug;37(2):527-30. doi: 10.1111/j.1471-4159.1981.tb00490.x.
9
[Mechanism of inhibition by chlorgyline and deprenyl of tyramine deamination by mitochondrial monoamine oxidase of rat liver].[氯吉兰和司来吉兰对大鼠肝脏线粒体单胺氧化酶脱氨酪胺的抑制机制]
Biokhimiia. 1980 Oct;45(10):1897-908.
10
Inhibition by deprenyl of dopamine uptake in rat striatum: a possible correlation between dopamine uptake and acetylcholine release inhibition.司来吉兰对大鼠纹状体多巴胺摄取的抑制作用:多巴胺摄取与乙酰胆碱释放抑制之间的可能关联。
Pol J Pharmacol Pharm. 1979 Jul-Aug;31(4):297-307.

引用本文的文献

1
Protective Effect of Selegiline (R-deprenyl) in Aminoglycoside-Induced Hearing Loss.司来吉兰(R-丙炔苯丙胺)对氨基糖苷类药物所致听力损失的保护作用
Neurochem Res. 2025 Jun 13;50(3):200. doi: 10.1007/s11064-025-04446-3.
2
Accumulation of I-Ioflupane Is a Useful Marker of the Efficacy of Selegiline Monotherapy in Drug-Naïve Parkinson's Disease.碘-123-碘氟烷的蓄积是司来吉兰单药治疗初治帕金森病疗效的有用标志物。
Front Aging Neurosci. 2017 Sep 29;9:321. doi: 10.3389/fnagi.2017.00321. eCollection 2017.
3
Characterization of extracellular dopamine clearance in the medial prefrontal cortex: role of monoamine uptake and monoamine oxidase inhibition.
内侧前额叶皮质细胞外多巴胺清除的特征:单胺摄取和单胺氧化酶抑制的作用。
J Neurosci. 2001 Jan 1;21(1):35-44. doi: 10.1523/JNEUROSCI.21-01-00035.2001.
4
Usefulness of a dopamine transporter PET ligand [(18)F]beta-CFT in assessing disability in Parkinson's disease.多巴胺转运体PET配体[(18)F]β-CFT在评估帕金森病残疾程度中的应用价值。
J Neurol Neurosurg Psychiatry. 1999 Dec;67(6):737-41. doi: 10.1136/jnnp.67.6.737.
5
Effect of low-dose treatment with selegiline on dopamine transporter (DAT) expression and amphetamine-induced dopamine release in vivo.司来吉兰低剂量治疗对体内多巴胺转运体(DAT)表达及苯丙胺诱导的多巴胺释放的影响。
Br J Pharmacol. 1999 Feb;126(4):997-1002. doi: 10.1038/sj.bjp.0702389.
6
Protection of the aged substantia nigra of the rat against oxidative damage by (-)-deprenyl.(-)-司来吉兰对大鼠老年黑质的氧化损伤保护作用
Br J Pharmacol. 1996 Apr;117(8):1756-60. doi: 10.1111/j.1476-5381.1996.tb15350.x.
7
New mechanisms of action of irreversible monoamine oxidase type B inhibitors.不可逆性单胺氧化酶B型抑制剂的新作用机制
J Psychiatry Neurosci. 1993 Jul;18(4):199-200.
8
The effect of L-deprenyl on behavior, cognitive function, and biogenic amines in the dog.L-司来吉兰对犬行为、认知功能及生物胺的影响。
Neurochem Res. 1993 Dec;18(12):1211-9. doi: 10.1007/BF00975038.
9
The effects of monoamine oxidase B inhibition on dopamine metabolism in rats with nigro-striatal lesions.单胺氧化酶B抑制对黑质纹状体损伤大鼠多巴胺代谢的影响。
Neurochem Res. 1994 Feb;19(2):153-9. doi: 10.1007/BF00966810.
10
Voltammetric detection of the release of 5-hydroxyindole compounds throughout the sleep-waking cycle of the rat.伏安法检测大鼠睡眠-清醒周期中5-羟吲哚化合物的释放情况。
Exp Brain Res. 1990;80(1):121-8. doi: 10.1007/BF00228853.